Perera, B. Lakshitha A.
Stewart, Russell
Furuta, Yutaka
Ezell, Kimberly M.
Rives, Lynette
Nunley, Bethany
McMinn, Ashley
Krokosky, Alyson
Neumann, Serena
Koziura, Mary E.
,
Hamid, Rizwan
Cogan, Joy D.
Cassini, Thomas A.
Gamazon, Eric R.
Phillips III, John A.
Tinker, Rory J.
Article History
Received: 30 April 2025
Accepted: 8 July 2025
First Online: 11 August 2025
Declarations
:
: VUMC UDN IRB Number 172005.
: E.R.G. has performed consulting for Thryv Therapeutics. E.R.G. is a co-inventor on patents for molecular signatures of cardiovascular phenotypes and metabolic health, use of RNAs as therapeutics and biomarkers in disease, and methods in metabolomics. R.S. was previously an employee of Singular Genomics, a genomics device manufacturer. R.S. holds company stock options from this employment. R.S. has not received compensation from or performed work for this company since July 2022.
: The authors declare no competing interests.